Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal Cancer

We analyzed the results of previously treated patients with metastatic colorectal cancer (mCRC) who received regorafenib plus FOLFIRI with the irinotecan dose escalation on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping. Thirteen patients with previously treated mCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Cheng-Jen, Huang, Ching-Wen, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Hu, Huang-Ming, Wu, I-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840952/
https://www.ncbi.nlm.nih.gov/pubmed/27938508
http://dx.doi.org/10.3727/97818823455816X14786040691928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840952/
https://www.ncbi.nlm.nih.gov/pubmed/27938508
http://dx.doi.org/10.3727/97818823455816X14786040691928

Ejemplares similares